GeneDx Holdings Corp. - Common Stock (WGS) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2023 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
WGS on Nasdaq
Shares outstanding
28,736,767
Price per share
$130.06
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
30,100,794
Total reported value
$3,243,258,025
% of total 13F portfolios
0.02%
Share change
-1,454,827
Value change
-$145,765,900
Number of holders
264
Price from insider filings
$130.06
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of GeneDx Holdings Corp. - Common Stock (WGS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CMLS Holdings LLC 12% -12% $438,313,315 -$56,167,274 3,630,826 -11% Keith A. Meister 22 Aug 2025
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 4.3% -23% $133,132,271 -$42,634,981 1,235,681 -24% WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 30 Sep 2025
GOLDMAN SACHS GROUP INC 3.9% -26% $106,945,408 -$30,453,041 1,106,752 -22% THE GOLDMAN SACHS GROUP, INC. 31 Mar 2025
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 3% -43% $104,696,231 -$67,567,346 867,265 -39% Summit Partners Public Asset Management, LLC 30 Jun 2025
FMR LLC 0.6% -94% $10,178,343 -$163,940,799 163,324 -94% FMR LLC 30 Jun 2025

As of 30 Sep 2025, 264 institutional investors reported holding 30,100,794 shares of GeneDx Holdings Corp. - Common Stock (WGS). This represents 105% of the company’s total 28,736,767 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of GeneDx Holdings Corp. - Common Stock (WGS) together control 75% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Corvex Management LP 11% 3,058,629 0% 12% $329,536,688
Casdin Capital, LLC 10% 3,007,164 -14% 27% $323,991,849
BlackRock, Inc. 5.3% 1,529,075 +6.6% 0% $164,742,539
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 4.2% 1,220,138 -25% 0.34% $131,457,668
VANGUARD GROUP INC 4.1% 1,170,422 -0.89% 0% $126,101,267
GOLDMAN SACHS GROUP INC 4.1% 1,168,180 +11% 0.02% $125,859,714
ORACLE INVESTMENT MANAGEMENT INC 3.1% 889,954 -3.5% 67% $95,883,644
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 2.9% 823,567 +7.3% 2.9% $88,731,109
T. Rowe Price Investment Management, Inc. 2.5% 718,003 -31% 0.05% $77,358,000
FRANKLIN RESOURCES INC 2.4% 681,381 +102% 0.02% $73,411,935
Zweig-DiMenna Associates LLC 2.1% 602,300 +2.8% 5% $64,891,802
JENNISON ASSOCIATES LLC 2.1% 598,426 +50% 0.04% $64,474,418
WESTFIELD CAPITAL MANAGEMENT CO LP 1.9% 544,094 -7.7% 0.25% $58,620,688
LORD, ABBETT & CO. LLC 1.8% 525,377 +21% 0.17% $56,604,000
FMR LLC 1.8% 503,309 +208% 0% $54,226,598
Invesco Ltd. 1.7% 494,072 -11% 0.01% $53,231,317
GEODE CAPITAL MANAGEMENT, LLC 1.7% 489,397 +0.97% 0% $52,735,613
RAYMOND JAMES FINANCIAL INC 1.7% 475,543 +15% 0.02% $51,235,002
MORGAN STANLEY 1.6% 467,812 -4% 0% $50,402,119
ARK Investment Management LLC 1.6% 446,979 0.29% $48,157,485
STATE STREET CORP 1.5% 439,806 +5.7% 0% $47,384,698
Pentwater Capital Management LP 1.5% 425,000 -65% 0.41% $45,789,500
Driehaus Capital Management LLC 1.4% 410,030 +35% 0.32% $44,176,632
WELLINGTON MANAGEMENT GROUP LLP 1.4% 395,731 -2.7% 0.01% $42,636,058
ALLIANCEBERNSTEIN L.P. 1.3% 360,063 -6.9% 0.01% $38,793,188

Institutional Holders of GeneDx Holdings Corp. - Common Stock (WGS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 295,471 $38,464,843 +$32,606,976 $130.06 9
2025 Q3 30,100,794 $3,243,258,025 -$145,765,900 $107.74 264
2025 Q2 31,497,581 $2,907,518,951 +$295,483,852 $92.31 227
2025 Q1 28,348,693 $2,510,003,276 +$418,105,244 $88.56 223
2024 Q4 23,530,387 $1,808,787,815 +$346,596,272 $76.86 197
2024 Q3 18,827,893 $799,061,608 +$96,660,654 $42.44 135
2024 Q2 16,284,875 $425,689,901 +$75,857,368 $26.14 88
2024 Q1 13,907,881 $126,979,303 +$14,357,147 $9.13 57
2023 Q4 11,655,169 $32,051,510 -$6,904,614 $2.75 44
2023 Q3 13,944,602 $50,758,006 -$946,111 $3.64 54
2023 Q2 13,953,292 $83,160,877 -$76,092,823 $5.96 57
2023 Q1 26,718,966 $9,627,559 +$9,627,632 $0.36 2